FIGURE 9: PATENT TYPES FOR TIRZEPATIDE FIGURE 10: ANNUAL PATENT FILINGS FOR TIRZEPATIDE FIGURE 11: DURATION OF PATENT PROTECTION FOR TIRZEPATIDE PERPETUATING HEALTH INEQUITIES The rise of GLP-1 products containing semaglutide and tirzepatide have had an immediate impact on the treatment of diabetes and obesity
Mixed effect linear regression is ideally suited to analyse using the modified intention-to-treat principle because it included multiple time points per person and all available data are modelled and extrapolated to predict missing data [35]
People stop taking a semaglutide medication, like Ozempic or Wegovy , for various reasons
This screening protects patient safety and ensures appropriate protocol design based on individual circumstances
Data also shows how rapidly these flagship products have come to fuel the majority of revenue for both companies, highlighting the revenue concentration characteristic of financialized business models
Confirm whether the medication uses semaglutide base form rather than a salt form, if semaglutide is prescribed